A number of new ionic titanocene compounds have been isolated and characterized. These exhibit significant cytotoxicity against a number of different human tumor cell lines including a defined cisplatin-resistant cell line. One of the compounds is an order of magnitude more active than its nonfunctionalized equivalent.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: